Bio-Thera Solutions, Ltd. (SHA:688177)
17.34
-0.45 (-2.53%)
Oct 22, 2026, 4:00 PM EDT
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 7.18 billion as of October 22, 2026. It is the 9,588th most valuable company in the world and the 2,059th biggest in China. Its market cap has decreased by 35.90% in one year.
Market Cap
7.18B
Enterprise Value
7.68B
Revenue
1.01B
Global Rank
Country Rank
#2,059 China
PE Ratio
n/a
ChartMarket Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 7.18B, a decrease of -71.20%. That is a compound annual growth rate of -17.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 7.18B | -25.06% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liaoning Chengda Biotechnology | 8.30B |
| Chengdu Easton Biopharmaceuticals | 8.19B |
| Vcanbio Cell & Gene Engineering Corp., | 8.16B |
| Jiangxi Fushine Pharmaceutical | 7.84B |
| Novogene | 7.83B |
| Daan Gene | 7.69B |
| Aurisco Pharmaceutical | 7.54B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 7.06B |